It was recently shown that TRAIL-sensitive cancer cells derived from human carcinomas of different origin can acquire the resistance to TRAIL-induced apoptosis in confluent cultures and spheroids [9,10]. This evidence concerns the gene TNFSF10 and carcinoma.